TruBridge (NASDAQ:TBRG) Major Shareholder Buys $178,163.90 in Stock

TruBridge, Inc. (NASDAQ:TBRG) major shareholder Pinetree Capital Ltd. acquired 8,935 shares of the stock in a transaction on Wednesday, November 12th. The stock was bought at an average price of $19.94 per share, with a total value of $178,163.90. Following the transaction, the insider directly owned 777,185 shares in the company, valued at approximately $15,497,068.90. This represents a 1.16% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Pinetree Capital Ltd. also recently made the following trade(s):

• On Friday, November 14th, Pinetree Capital Ltd. bought 18,933 shares of TruBridge stock. The shares were bought at an average price of $20.23 per share, for a total transaction of $383,014.59.
• On Thursday, November 13th, Pinetree Capital Ltd. purchased 21,035 shares of TruBridge stock. The stock was bought at an average cost of $20.41 per share, with a total value of $429,324.35.

TruBridge Trading Down 0.2%

TBRG stock traded down $0.05 during trading on Friday, hitting $20.37. The company had a trading volume of 101,848 shares, compared to its average volume of 147,597. The stock has a market cap of $305.73 million, a price-to-earnings ratio of -24.25 and a beta of 0.57. The company has a quick ratio of 1.79, a current ratio of 1.80 and a debt-to-equity ratio of 0.94. The firm has a 50-day moving average price of $20.10 and a 200-day moving average price of $21.74. TruBridge, Inc. has a 12 month low of $15.40 and a 12 month high of $32.00.

TruBridge (NASDAQ:TBRG) last released its earnings results on Thursday, November 6th. The company reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.48. The company had revenue of $86.11 million during the quarter, compared to the consensus estimate of $85.56 million. TruBridge had a positive return on equity of 3.30% and a negative net margin of 3.63%. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts predict that TruBridge, Inc. will post 0.07 earnings per share for the current year.

Hedge Funds Weigh In On TruBridge

A number of large investors have recently bought and sold shares of the company. Kingsview Wealth Management LLC bought a new stake in TruBridge during the first quarter worth about $240,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in TruBridge during the first quarter worth approximately $370,000. Jefferies Financial Group Inc. bought a new stake in TruBridge in the 1st quarter valued at $256,000. Vanguard Group Inc. increased its position in TruBridge by 2.6% during the 1st quarter. Vanguard Group Inc. now owns 663,862 shares of the company’s stock worth $18,269,000 after buying an additional 16,715 shares during the period. Finally, Invesco Ltd. raised its stake in TruBridge by 177.7% in the 1st quarter. Invesco Ltd. now owns 151,489 shares of the company’s stock worth $4,169,000 after purchasing an additional 96,931 shares in the last quarter. Institutional investors and hedge funds own 88.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on TBRG. Weiss Ratings reiterated a “sell (e+)” rating on shares of TruBridge in a research report on Friday, October 31st. BMO Capital Markets assumed coverage on shares of TruBridge in a research report on Thursday. They issued a “market perform” rating and a $19.50 price target on the stock. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $25.50.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.